1 |
Kyle RA. Multiple myeloma: review of 869 cases. Mayo Clin Proc 1975; 50: 29-40.
|
2 |
Batsakis JG. Pathology consultation. Plasma cell tumors of the head and neck. Ann Otol Rhinol Laryngol 1983; 92: 311-3.
DOI
|
3 |
Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. CA Cancer J Clin 1995; 45: 8-30.
DOI
|
4 |
Holland J, Trenkner DA, Wasserman TH, Fineberg B. Plasmacytoma. Treatment results and conversion to myeloma. Cancer 1992; 69: 1513-7.
DOI
|
5 |
Kyle RA. Diagnostic criteria of multiple myeloma. Hematol Oncol Clin North Am 1992; 6: 347-58.
DOI
|
6 |
Lee SH, Huang JJ, Pan WL, Chan CP. Gingival mass as the primary manifestation of multiple myeloma: report of two cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 82: 75-9.
DOI
|
7 |
Epstein JB, Voss NJ, Stevenson-Moore P. Maxillofacial manifestations of multiple myeloma. An unusual case and review of the literature. Oral Surg Oral Med Oral Pathol 1984; 57: 267-71.
DOI
|
8 |
Lambertenghi-Deliliers G, Bruno E, Cortelezzi A, Fumagalli L, Morosini A. Incidence of jaw lesions in 193 patients with multiple myeloma. Oral Surg Oral Med Oral Pathol 1988; 65: 533-7.
DOI
|
9 |
Mondello P, Pitini V, Arrigo C, Mondello S, Mian M, Altavilla G. Necrotizing fasciitis as a rare complication of osteonecrosis of the jaw in a patient with multiple myeloma treated with lenalidomide: case report and review of the literature. Springerplus 2014; 3: 123.
DOI
|
10 |
Lee SH, Chan RC, Chang SS, Tan YL, Chang KH, Lee MC, et al. Use of bisphosphonates and the risk of osteonecrosis among cancer patients: a systemic review and meta-analysis of the observational studies. Support Care Cancer 2014; 22: 553-60.
DOI
|
11 |
Utreja A, Almas K, Javed F. Dental extraction as a risk factor for bisphosphonate related osteonecrosis of the jaw in cancer patients: an update. Odontostomatol Trop 2013; 36: 38-46.
|
12 |
Sukpanichnant S, Cousar JB, Leelasiri A, Graber SE, Greer JP, Collins RD. Diagnostic criteria and histologic grading in multiple myeloma: histologic and immunohistologic analysis of 176 cases with clinical correlation. Hum Pathol 1994; 25: 308-18.
DOI
|
13 |
Blade J, Kyle RA, Greipp PR. Multiple myeloma in patients younger than 30 years. Report of 10 cases and review of the literature. Arch Intern Med 1996; 156: 1463-8.
DOI
|
14 |
Matsumura S, Kishino M, Ishida T, Furukawa S. Radiographic findings for solitary plasmacytoma of the bone in the anterior wall of the maxillary sinus: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 89: 651-7.
DOI
|
15 |
Croucher PI, Apperley JF. Bone disease in multiple myeloma. Br J Haematol 1998; 103: 902-10.
DOI
|
16 |
Mozaffari E, Mupparapu M, Otis L. Undiagnosed multiple myeloma causing extensive dental bleeding: report of a case and review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 94: 448-53.
DOI
|
17 |
Coleman R, Gnant M, Morgan G, Clezardin P. Effects of bone-targeted agents on cancer progression and mortality. J Natl Cancer Inst 2012; 104: 1059-67.
DOI
|
18 |
Yaegaki K, Kameyama T, Takenaka M, Kimura T, Sujaku C, Tanimura A. Myelomatosis (IgD, lambda) discovered by oral manifestation. Int J Oral Surg 1985; 14: 381-4.
DOI
|
19 |
Badros A, Weikel D, Salama A, Goloubeva O, Schneider A, Rapoport A. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol 2006; 24: 945-52.
DOI
|
20 |
Assael LA. New foundations in understanding osteonecrosis of the jaws. J Oral Maxillofac Surg 2004; 62: 125-6.
DOI
|
21 |
Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 2007; 65: 369-76.
DOI
|